Louis Chesler

26PUBLICATIONS
403CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCancer geneticsNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

|Jun 24, 2026
Anti-Tumor Activity of Cdk2/9 Inhibitor Fadraciclib in an In Vivo Model of Temozolomide Refractory Neuroblastoma.

|Feb 25, 2026
A disease model resource reveals core principles of tissue-specific cancer evolution.

Sebastian Mueller, Niklas de Andrade Krätzig, Markus Tschurtschenthaler

|Jan 15, 2026
Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder Analysis.

Susanne A Gatz, Julia Glade-Bender, Andrew D J Pearson

|Dec 12, 2025
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.

Juliet C Gray, Rebekah Weston, Cormac Owens

|Dec 11, 2025
Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models.

Melanie Schoof, Tuyu Zheng, Martin Sill

Pageof 5

Frequent Collaborators

7 joint publications

Pascal Chastagner

7 joint publications

Sally L George

5 joint publications

Yann Jamin

5 joint publications

Evon Poon